A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel
Conditions
Interventions
- DRUG: HM30181 methanesulfonate monohydrate plus oral paclitaxel capsules
Sponsor
Athenex, Inc.
Collaborators
- [object Object]
- [object Object]